Avoiding the vicious cycle of prolonged opioid use in Crohn's disease

American Journal of Gastroenterology

Volumn 100, Issue 10, 2005, Pages 2230-2232

  Jones, Jennifer L ^a   Loftus Jr , Edward V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; CIGARETTE SMOKING; COGNITION; CROHN DISEASE; DISEASE ACTIVITY; DRUG MEGADOSE; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; LONG TERM CARE; MEDICAL DECISION MAKING; OPIATE ADDICTION; PATIENT CARE; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; CHRONIC DISEASE; DRUG ADMINISTRATION; EDITORIAL; PAIN; RISK FACTOR;

ANALGESICS, OPIOID; CHRONIC DISEASE; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; HUMANS; PAIN; RISK FACTORS;

EID: 27744529436     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.50803.x     Document Type: Review

References (15)

1. Gatchel RJ. A biopsychosocial overview of pretreatment screening of patients with pain. Clin J Pain 2001 17 : 192 9.
2. Ballantyne JC Mao J. Opioid therapy for chronic pain. N Engl J Med 2003 349 : 1943 53.
3. De Schepper HU Cremonini F Park MI, et al. Opioids and the gut: Pharmacology and current clinical experience. Neurogastroenterol Motil 2004 16 : 383 94.
4. Wood JD Galligan JJ. Function of opioids in the enteric nervous system. Neurogastroenterol Motil 2004 16 ( S2 17 28.
5. Chapman SL Byas-Smith MG Reed BA. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 2002 18 ( 4 suppl S83 90.
6. Aronoff GM. Opioids in chronic pain management: Is there a significant risk of addiction? Curr Rev Pain 2000 4 : 112 21.
7. Anonymous. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Management and the American Pain Society. Clin J Pain 1997 13 : 6 8.
8. Brody J. When it comes to severe pain, doctors still have much to learn. N Y Times Feb 15, 2005.
9. Kaplan MA Korelitz BI. Narcotic dependence in inflammatory bowel disease. J Clin Gastroenterol 1988 10 : 275 8.
10. Walker EA Gelfand MD Gelfand AN. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry 1996 18 : 220 9.
11. Guthrie E Jackson J Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and crohn's disease. Am J Gastroenterol 2002 97 : 1994 9.
12. Simren M Axelsson J Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002 97 : 389 96.
13. Edwards JT Radford-Smith GL Florin TH. Chronic nacotic use in inflammatory bowel disease patients: Prevalence and clinical characteristics. J Gastroenterol Hepatol 2001 16 : 1235 8.
14. Lichtenstein G Cohen RD Feagan BG, et al. Safety of infliximab and other Crohn's disease therapies-updated Treat™ registry data with over 10,000 patient-years of follow-up (abstract). Gastroenterology 2005 124 ( 4 suppl 2 A580.
15. Cross RK Wilson KT Binion DG. Narcotic use in patients with Crohn's disease. Am J Gastroenterol 2005 100 : 2225 9.